| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |